BIOMAT Database Logo BIOMAT Database Logo

[Synthesis and structure-activity relationship of N-(2-arylethyl) isoquinoline derivatives as anti-cancer agents]. 2012

Yan-Xiang Wang, and Wu-Li Zhao, and Chong-Wen Bi, and Yang-Biao Li, and Rong-Guang Shao, and Dan-Qing Song
Institute of Medicinal Biotechnology, China Academy of Medical Science and Peking Union Medical College, Beijing 100050, China.

A series of novel N-(2-arylethyl) isoquinoline derivatives were designed, synthesized and evaluated for their anti-cancer activities. Among these analogs, compound 9a exhibited the potential anti-cancer activities on HepG2 and HCT116 cells with IC50 values of 2.52 and 1.99 microg x mL(-1), respectively. Cell cycle was blocked at S phase of HepG2 cells treated with 9a by flow cytometry detection. Our results provided a basis for the development of a new series of anti-cancer candidates.

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045325 HCT116 Cells Human COLORECTAL CARCINOMA cell line. HCT 116 Cells,HCT-116 Cells,Cell, HCT 116,Cell, HCT-116,Cell, HCT116,Cells, HCT 116,Cells, HCT-116,Cells, HCT116,HCT 116 Cell,HCT-116 Cell,HCT116 Cell
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D056945 Hep G2 Cells A human liver tumor cell line used to study a variety of liver-specific metabolic functions. Cell Line, Hep G2,Cell Line, Hepatoblastoma G2,Hep G2 Cell Line,HepG2 Cells,Hepatoblastoma G2 Cell Line,Cell, Hep G2,Cell, HepG2,Cells, Hep G2,Cells, HepG2,Hep G2 Cell,HepG2 Cell
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory

Related Publications

Yan-Xiang Wang, and Wu-Li Zhao, and Chong-Wen Bi, and Yang-Biao Li, and Rong-Guang Shao, and Dan-Qing Song
Synthesis and structure-activity relationship of N-(2-arylethyl) isoquinoline derivatives as human scavenger receptor CD36 antagonists.
April 2011, European journal of medicinal chemistry,
Yan-Xiang Wang, and Wu-Li Zhao, and Chong-Wen Bi, and Yang-Biao Li, and Rong-Guang Shao, and Dan-Qing Song
Synthesis, structure-activity relationship and in vitro biological evaluation of N-arylethyl isoquinoline derivatives as Coxsackievirus B3 inhibitors.
October 2011, Bioorganic & medicinal chemistry letters,
Yan-Xiang Wang, and Wu-Li Zhao, and Chong-Wen Bi, and Yang-Biao Li, and Rong-Guang Shao, and Dan-Qing Song
Synthesis and structure-activity relationship of 2-aminobenzophenone derivatives as antimitotic agents.
June 2002, Journal of medicinal chemistry,
Yan-Xiang Wang, and Wu-Li Zhao, and Chong-Wen Bi, and Yang-Biao Li, and Rong-Guang Shao, and Dan-Qing Song
Synthesis and structure-activity relationship of 5-substituent-2(1H)-pyridone derivatives as anti-fibrosis agents.
March 2012, Bioorganic & medicinal chemistry letters,
Yan-Xiang Wang, and Wu-Li Zhao, and Chong-Wen Bi, and Yang-Biao Li, and Rong-Guang Shao, and Dan-Qing Song
Synthesis and Structure-Activity Relationship of Pyxinol Derivatives as Novel Anti-Inflammatory Agents.
April 2020, ACS medicinal chemistry letters,
Yan-Xiang Wang, and Wu-Li Zhao, and Chong-Wen Bi, and Yang-Biao Li, and Rong-Guang Shao, and Dan-Qing Song
Synthesis and Structure Activity Relationship of Some Indole Derivatives as Potential Anti-inflammatory Agents.
December 2017, Acta chimica Slovenica,
Yan-Xiang Wang, and Wu-Li Zhao, and Chong-Wen Bi, and Yang-Biao Li, and Rong-Guang Shao, and Dan-Qing Song
Synthesis and structure-activity relationship studies of parthenolide derivatives as potential anti-triple negative breast cancer agents.
March 2019, European journal of medicinal chemistry,
Yan-Xiang Wang, and Wu-Li Zhao, and Chong-Wen Bi, and Yang-Biao Li, and Rong-Guang Shao, and Dan-Qing Song
Triptolide derivatives as potential multifunctional anti-Alzheimer agents: Synthesis and structure-activity relationship studies.
February 2018, Bioorganic & medicinal chemistry letters,
Yan-Xiang Wang, and Wu-Li Zhao, and Chong-Wen Bi, and Yang-Biao Li, and Rong-Guang Shao, and Dan-Qing Song
Structure-activity relationship of novel (benzoylaminophenoxy)phenol derivatives as anti-prostate cancer agents.
October 2018, Bioorganic & medicinal chemistry,
Yan-Xiang Wang, and Wu-Li Zhao, and Chong-Wen Bi, and Yang-Biao Li, and Rong-Guang Shao, and Dan-Qing Song
Design, synthesis, biological activity and structure-activity relationship studies of chalcone derivatives as potential anti-Candida agents.
August 2018, The Journal of antibiotics,
Copied contents to your clipboard!